HCL Technologies announced an all-cash investment of Rs14.27 billion to acquire a 10.46% equity stake in Sarvam AI at a post-money valuation of $1.5 billion. The companies expect the transaction to be completed within two weeks of signing.
Sarvam AI, incorporated in July 2023, develops training and inference infrastructure, builds frontier models across text and other modalities, and offers AI products for enterprises, developers and government customers. The firm reported revenue of Rs451 million in fiscal year 2026, up from Rs15 million in fiscal year 2025.
The strategic rationale HCLTech provided is centered on accelerating the firm’s ability to develop industry- and client-specific language models and AI solutions for its global client base. HCLTech plans to leverage and expand Sarvam’s multilingual AI capabilities within India and internationally, targeting sovereign AI initiatives and enterprise deployments that require localized models and compliance-focused implementations.
HCLTech also signaled an intention to push adoption of sovereign AI solutions aimed at governments, regulated industries and enterprises that require localized, secure and compliant AI environments. The company framed direct access to large language model technology and industry-specific use cases as a way to speed the buildout of capabilities.
In commentary on the transaction, Morgan Stanley said that taking a minority equity stake could help align the incentives of the two companies. The firm also cautioned that, given how quickly the AI landscape is evolving, there is a risk that the current investment could become obsolete if the assumed success rate for such ventures is low.
The announcement coincided with a rise in HCLTech shares following the disclosure, reflecting investor interest in the company’s expanded exposure to generative AI and sovereign-use cases.
Context for markets and clients
The deal links a large IT services provider to a rapidly scaling AI infrastructure and model developer. For HCLTech, the transaction aims to create nearer-term access to LLM technology and multilingual models that can be tailored for specific industries and regulatory environments. For Sarvam AI, the cash infusion represents growth capital as it scales revenue and product deployment.